课题基金 / 基金详情

项目摘要

项目成果

DAVID B ROZEMA的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Given its central role in metabolism, the secretion of circulating proteins, and infectious disorders, a large number of genetic or acquired disorders could be corrected by liver-directed delivery of nucleic acids to instill beneficial functions or inhibit deleterious ones. However, a safe and effective delivery method for transferring nucleic acids molecules to hepatocytes remains to be perfected. To date, most in vivo nucleic acid delivery vehicles have been colloid particles with size grater than 50 nm. We believe that we have found an innovative strategy for the delivery of molecular conjugates of siRNA. This formulation relies upon several new innovations: the development-as a result of Phase I research- of membrane lytic polymers, the ability to reversibly mask the positive charges of these polymers until they reach an acidic environment such as the endosome/lysosome, the ability to target these masked membrane lytic polymers to hepatocytes in vivo, and the formation of siRNA-polymer conjugates that like polymers can be targeted to hepatocytes in vivo.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Amphiphilic Polycations for Nucleic Acid Delivery
  • 批准号:
    6934028
  • 项目类别:
  • 资助金额:
    $13.43万
  • 财政年份:
    2005
  • 负责人:
    DAVID B ROZEMA
  • 依托单位:
Amphiphilic Polycations for Nucleic Acid Delivery
  • 批准号:
    7272444
  • 项目类别:
  • 资助金额:
    $58.84万
  • 财政年份:
    2005
  • 负责人:
    DAVID B ROZEMA
  • 依托单位:
Delivery of Oligonucleotides to Hepatocytes In Vivo
  • 批准号:
    6789700
  • 项目类别:
  • 资助金额:
    $42.0万
  • 财政年份:
    2001
  • 负责人:
    DAVID B ROZEMA
  • 依托单位:
Delivery of Oligonucleotides to Hepatocytes In Vivo
  • 批准号:
    6933188
  • 项目类别:
  • 资助金额:
    $37.08万
  • 财政年份:
    2001
  • 负责人:
    DAVID B ROZEMA
  • 依托单位: